QuDoS

Views & Analysis

Monitoring people who are on disease modifying drugs (DMDs) is paramount to providing safe, high-quality MS care.

Views & Analysis

Best healthcare professionals working in multiple sclerosis (MS) honoured QuDoS awards.

News

Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.